Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 13, 2010View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderMay 11, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 6, 2010View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 3, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 29, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 14, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 7, 2010View HTMLDownload DOCDownload PDF
ARSAn annual report to security holders.Apr 5, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 5, 2010View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KApr 2, 2010View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Mar 26, 2010View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveMar 26, 2010View HTMLDownload DOCDownload PDFDownload XLS
10-K/AAmendment to a previously filed 10-KMar 25, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 24, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 16, 2010View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-123

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information